Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2440082rdf:typepubmed:Citationlld:pubmed
pubmed-article:2440082lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C0024115lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C0599779lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C0684224lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C0038891lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C0205463lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C0439611lld:lifeskim
pubmed-article:2440082lifeskim:mentionsumls-concept:C1515926lld:lifeskim
pubmed-article:2440082pubmed:dateCreated1987-8-5lld:pubmed
pubmed-article:2440082pubmed:abstractTextThe diffuse obstructive and infiltrative lung diseases (e.g. bronchitis, asthmatic bronchitis, fibrosing alveolitis, sarcoidosis) contribute significantly to human morbidity and mortality. Disturbance of ventilation and perfusion represents a major physiologic defect in these diseases, resulting in pulmonary hypertension, cor pulmonale and right heart failure. Immunologic and surfactant alterations play a prominent role in these diseases. There is a growing body of evidence indicating that surfactant is a most important material in maintaining airway patency. General concepts regarding these functions in human adult lung diseases and results of investigations of surfactant in an animal model of bleomycin-induced lung fibrosis are presented.lld:pubmed
pubmed-article:2440082pubmed:languageenglld:pubmed
pubmed-article:2440082pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2440082pubmed:citationSubsetIMlld:pubmed
pubmed-article:2440082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2440082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2440082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2440082pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2440082pubmed:statusMEDLINElld:pubmed
pubmed-article:2440082pubmed:issn0025-7931lld:pubmed
pubmed-article:2440082pubmed:authorpubmed-author:ThrallR SRSlld:pubmed
pubmed-article:2440082pubmed:authorpubmed-author:SulavikS BSBlld:pubmed
pubmed-article:2440082pubmed:issnTypePrintlld:pubmed
pubmed-article:2440082pubmed:volume51 Suppl 1lld:pubmed
pubmed-article:2440082pubmed:ownerNLMlld:pubmed
pubmed-article:2440082pubmed:authorsCompleteYlld:pubmed
pubmed-article:2440082pubmed:pagination10-4lld:pubmed
pubmed-article:2440082pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:meshHeadingpubmed-meshheading:2440082-...lld:pubmed
pubmed-article:2440082pubmed:year1987lld:pubmed
pubmed-article:2440082pubmed:articleTitleSurfactant and physiologic alterations in an animal model of adult human lung disease. A preliminary report.lld:pubmed
pubmed-article:2440082pubmed:publicationTypeJournal Articlelld:pubmed